Nirogy Therapeutics vs R2M Pharma, Inc.

Nirogy Therapeutics logo

Nirogy Therapeutics

Pioneering innovative small molecules to disrupt metabolic and immune pathways, advancing therapeutic solutions for cancer and autoimmune diseases

2-10 employees · est. 2013

VS
R2M Pharma, Inc. logo

R2M Pharma, Inc.

R2M is a collaborative pharmaceutical company that works with you throughout the discovery and development phase

17 employees · est. 2017 · South San Francisco, United...

Nirogy Therapeutics is the older company (2013 vs 2017); R2M Pharma, Inc. is the larger of the two.

Side-by-Side Comparison

Nirogy Therapeutics R2M Pharma, Inc.
Founded
2013 older 2017
Headquarters
Not tracked yet South San Francisco, United States
Employees
2-10 17 larger
Industry
Biopharma, Biotechnology, Pharmaceutical Biotechnology, Health Care, Pharmaceutical
Funding Stage
Series A Not tracked yet
Total Funding
$18.50M Not tracked yet
Funding Rounds
2 Not tracked yet
Taxonomy
Small MoleculesCellular TransportersTumor MicroenvironmentMetabolic PathwaysImmune PathwaysOncology +7 Pharmaceutical CompanyResearch OrganizationSmall MoleculesPreclinical DevelopmentDrug DiscoveryMedical Indications +3
Website
nirogytx.com r2mpharma.com
Nirogy Therapeutics logo

About Nirogy Therapeutics

Nirogy Therapeutics is a cutting-edge biotechnology venture, making waves in the Biopharma and Biotechnology sectors since its inception in 2013. The company's core mission, encapsulated in its slogan, "Pioneering innovative small molecules to disrupt metabolic and immune pathways, advancing therape...

R2M Pharma, Inc. logo

About R2M Pharma, Inc.

R2M Pharma, Inc. is a fast growing biotechnology research organization founded in 2017, with a focus on the discovery of high quality small molecules preclinical development compounds for the treatment of unmet medical indications. Their slogan, "R2M is a collaborative pharmaceutical company that wo...

Also comparing in this category

We will tell you when either one moves

BounceWatch watches Nirogy Therapeutics and R2M Pharma, Inc. for new funding, fast hiring, new executives and a change of software vendor. When one happens, it is in your next e-mail.

Get notified when Nirogy Therapeutics or R2M Pharma, Inc. moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

Frequently Asked Questions

Nirogy Therapeutics was founded in 2013, with 2-10 employees. Nirogy Therapeutics is a cutting-edge biotechnology venture, making waves in the Biopharma and Biotechnology sectors since its inception in 2013. The company's core mission, encapsulated in its slogan. R2M Pharma, Inc. was founded in 2017, based in South San Francisco, United States, with 17 employees. R2M Pharma, Inc. is a fast growing biotechnology research organization founded in 2017, with a focus on the discovery of high quality small molecules preclinical development compounds for the treatmen.
Nirogy Therapeutics has raised $18.50M and R2M Pharma, Inc. no disclosed funding. Latest stage: Nirogy Therapeutics Series A.
Both work in Biotechnology and Pharmaceutical and list small molecules among their focus areas.

Compare Nirogy Therapeutics with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Nirogy Therapeutics on 2 Apr 2026, and R2M Pharma, Inc. on 15 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes